Market Research Report
North America Genetic Testing Market (2019-2025)
|Published by||KBV Research||Product code||911079|
|Published||Content info||81 Pages
Delivery time: 1-2 business days
|North America Genetic Testing Market (2019-2025)|
|Published: August 31, 2019||Content info: 81 Pages||
The North America Genetic Testing Market would witness market growth of 10.6% CAGR during the forecast period (2019-2025).
The incidence of genetic disorders has grown dramatically, which can be caused by several factors, including geographical and environmental changes, significant changes in food habits, pollution, and exposure to risky radiations or chemicals. Genetic testing also serves to evaluate relationships between relatives, including mother, father, half-brother, half-sister, and other people. Forensics and genetic testing have greatly helped the law and order. The overall industry for genetic tests has been expanding and is anticipated to grow rapidly in the near future since more organizations are joining this market.
Diagnostic tests are used to detect or exclude a particular genetic or chromosomal condition. Often genetic testing is used to verify a diagnosis when physical signs and symptoms are suspected of a particular condition. Diagnostic tests may be performed before and at any moment of birth, but not for each gene or genetic condition. Diagnostic test findings can affect a person's health care and disorder management decisions.
Based on Type, the market is segmented into Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types. Based on Technology, the market is segmented into Cytogenetic Testing, Biochemical Testing and Molecular Testing. Based on Application, the market is segmented into Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).